Medicines For Europe Sets Out Vision For Biosimilars Reforms

Proposed Policy Priorities Outline Opportunities For Europe

 
• By Dave Wallace
  
Isabell Remus opened the biosimilars conference in Amsterdam (Medicines for Europe)

More from Medicines for Europe

More from Policy & Regulation